Skip to main content

Table 2 Demographic and clinical characteristic of people living with HIV/AIDS diagnosed with TB at enrollment and during follow-up in the ClinSurv HIV Cohort, Germany 2001ā€“2011

From: Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors

Characteristics

Ā 

Female

Male

Total

Ā Ā 

Nā€‰=ā€‰66 (28.3%)

Nā€‰=ā€‰167 (71.7%)

Nā€‰=ā€‰233 (100%)

Median age at enrollment (Nā€‰=ā€‰232/1 missing data)

Median [IQR]

31 [26ā€“45]

40 [32ā€“47]

37 [30ā€“45]

Median age at the time of TB diagnosis, years (Nā€‰=ā€‰251/1 missing data)

Median [IQR]

32 [28ā€“39]

40 [32ā€“48]

37 [31ā€“45]

Region of origin (Nā€‰=ā€‰223/10 missing data)

N. (%)

Ā Ā Ā 

ā€ƒā€ƒā€‰Germany

Ā 

8 (12.5)

81 (50.9)

89 (39.9)

ā€ƒā€ƒā€‰Sub-Saharan Africa

Ā 

41 (64.1)

41 (25.8)

82 (36.8)

ā€ƒā€ƒā€‰Other countries

Ā 

15 (23.4)

37 (23.3)

52 (23.3)

HIV-transmission risk group (Nā€‰=ā€‰214/19 missing data)

N. (%)

Ā Ā Ā 

ā€ƒā€ƒā€‰MSM

Ā 

---

67 (43.8)

67 (31.3)

ā€ƒā€ƒā€‰PWID

Ā 

3 (4.9)

17 (11.1)

20 (9.4)

ā€ƒā€ƒā€‰HPC

Ā 

54 (88.5)

43 (28.1)

97 (45.3)

ā€ƒā€ƒā€‰Othersā€ 

Ā 

4 (6.6)

26 (16.9)

30 (14.0)

Median CD4+ blood cell count at enrollment (Nā€‰=ā€‰221/12 missing data)

Median [IQR]

197 [67ā€“349]

204 [67ā€“375]

189 [66ā€“348]

Median CD4+ blood cell count at the time of TB diagnosis (Nā€‰=ā€‰194/39 missing data)

Median [IQR]

211 [65ā€“339]

198 [47ā€“339]

216 [69ā€“350]

Median viral load at enrollment (log10copies/ml) (Nā€‰=ā€‰210/23 missing data)

Median [IQR]

4.8 [3.6-5.4]

4.7 [3.4-5.5]

4.9 [3.6-5.3]

Median viral load at the time of TB diagnosis (Nā€‰=ā€‰145/88 missing data)

Median [IQR]

5.0 [4.3-5.6]

5.2 [4.5-5.7]

5.9 [3.9-5.5]

Hepatitis B* (Nā€‰=ā€‰233)

Median [IQR]

25 (37.9)

39 (23.4)

64 (27.5)

Hepatitis C* (Nā€‰=ā€‰233)

Median [IQR]

5 (7.6)

18 (10.8)

23 (9.9)

Diabetes mellitus* (Nā€‰=ā€‰233)

Median [IQR]

2 (3.0)

5 (3.0)

7 (3.0)

cARTā€” (Nā€‰=ā€‰233)

Median [IQR]

31 (50.0)

99 (59.3)

130 (55.8)

Died (Nā€‰=ā€‰233)

N. (%)

4 (10.6)

18 (10.8)

25 (10.7)

  1. TB, tuberculosis; MSM, men who have sex with men; PWID, person who inject drugs; HPC, high HIV-prevalence countries; cART, combination antiretroviral therapy; IQR, interquartile range.
  2. *At any time during follow-up.
  3. ā€ Others included heterosexual, blood transfusion and mother to child transmission.
  4. ā€”cART initiated during follow-up at any time prior to TB diagnosis.